"We are excited about this opportunity," said David Cunic, CEO of Pazoo, Inc. "This agreement aligns with our mission to ensure the quality and consistency of cannabis-derived products. The effectiveness of this product along with our growing laboratory presence will allow us to set a high-standard for the purity of medicinal cannabis as this industry matures. This is the first of many products and services that we have and will be adding to the CannabisKing distribution channel."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.